Ferda Arı
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Ferrocene Chemistry and Applications
- Click Chemistry and Applications
Papers in
- Oncology 24
- Metal complexes synthesis and properties 20
-
- Synthesis and biological activity 11
- Synthesis and Characterization of Heterocyclic Compounds 9
- Co-authors
- Engı̇n Ulukaya (53 shared papers)Veysel T. Yılmaz (13 shared papers)Merve Erkısa (18 shared papers)Emel Guney (4 shared papers)Mehmet Sarımahmut (10 shared papers)Nazlıhan Aztopal (14 shared papers)Didem Karakaş (5 shared papers)KONSTANTINOS S. DIMAS (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry (7 papers)Chemistry & Biodiversity (4 papers)Anti-Cancer Agents in Medicinal Chemistry (3 papers)Cell Biochemistry and Function (3 papers)European Journal of Medicinal Chemistry (3 papers)
- Partner nations
- TürkiyeUnited KingdomGreece
In The Last Decade
Ferda Arı
84 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 103
- Oncology 660
- Organic Chemistry 606
- Toxicology 46
- Cancer Research 141
- Molecular Biology 553
Countries citing papers authored by Ferda Arı
This map shows the geographic impact of Ferda Arı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferda Arı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferda Arı more than expected).
Fields of papers citing papers by Ferda Arı
This network shows the impact of papers produced by Ferda Arı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferda Arı. The network helps show where Ferda Arı may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferda Arı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 144 | |
| 2 | 2017 | 92 | |
| 3 | 2017 | 83 | |
| 4 | 2010 | 76 | |
| 5 | 2012 | 68 | |
| 6 | 2011 | 63 | |
| 7 | 2013 | 63 | |
| 8 | 2022 | 62 | |
| 9 | 2010 | 58 | |
| 10 | 2013 | 55 | |
| 11 | 2019 | 54 | |
| 12 | 2016 | 48 | |
| 13 | 2017 | 45 | |
| 14 | 2010 | 39 | |
| 15 | 2013 | 39 | |
| 16 | 2014 | 39 | |
| 17 | 2015 | 39 | |
| 18 | 2017 | 34 | |
| 19 | 2019 | 33 | |
| 20 | 2014 | 32 |
About Ferda Arı
Ferda Arı is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Pharmacology and Toxicology, having authored 90 papers that have together received 1.8k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (20 papers), Synthesis and biological activity (11 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers), Epigenetics and DNA Methylation (7 papers), Lichen and fungal ecology (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). The work is most often cited by research in Oncology (660 citations), Organic Chemistry (606 citations), Toxicology (46 citations), Cancer Research (141 citations) and Molecular Biology (553 citations). Ferda Arı has collaborated with scholars based in Türkiye, United Kingdom and Greece. Frequent co-authors include Engı̇n Ulukaya, Veysel T. Yılmaz, Merve Erkısa, Emel Guney, Mehmet Sarımahmut, Nazlıhan Aztopal, Didem Karakaş, KONSTANTINOS S. DIMAS, Buse Cevatemre and Serap Çelikler. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Chemistry & Biodiversity, Anti-Cancer Agents in Medicinal Chemistry, Cell Biochemistry and Function and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.